Sera Prognostics - Class A (SERA) closed at $1.98 on November 12, 2026, up 2.1% from the previous close, on volume of 18,784 shares (30-day average 30,578).
Data as of November 12, 2026.
These healthcare stocks have tumbled in 2026, yet Quant ratings stay positive
Seeking Alpha News (Tue, 10-Nov 12:38 PM ET)
SERA PROGNOSTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
PRNewswire (Wed, 4-Nov 4:05 PM ET)
PRNewswire (Wed, 21-Oct 4:05 PM ET)
PRNewswire (Tue, 25-Aug 8:01 AM ET)
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
PRNewswire (Wed, 19-Aug 4:30 PM ET)
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
Sera Prognostics - Class A trades on the NASDAQ stock market under the symbol SERA.
As of November 13, 2026, SERA stock price climbed to $2.00 with 9,482 million shares trading.
SERA has a beta of 0.81, meaning it tends to be less sensitive to market movements. SERA has a correlation of 0.02 to the broad based SPY ETF.
SERA has a market cap of $78.90 million. This is considered a Micro Cap stock.
Last quarter Sera Prognostics - Class A reported $42,000 in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-34,000 and missed earnings estimates by -$.02.
In the last 3 years, SERA traded as high as $12.36 and as low as $1.37.
The top ETF exchange traded funds that SERA belongs to (by Net Assets): VTI, VXF, IWC, BUSM, AVSC.
SERA has underperformed the market in the last year with a price return of -35.9% while the SPY ETF gained +11.3%. However, in the short term, SERA had mixed performance relative to the market. It has outperformed in the last 3 months, returning -1.0% vs -2.3% return in SPY. But in the last 2 weeks, SERA shares have been beat by the market, returning -2.9% compared to an SPY return of -2.2%.
SERA support price is $1.89 and resistance is $2.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SERA shares will trade within this expected range on the day.
